Description
THERAPEUTIC APHERESIS SERVICES
Base award description: EO14042 - THERAPEUTIC APHERESIS SERVICES
Modification chain · 3 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2023-10-01+$12,124= $12,124
- Mod P000012023-12-12+$12,124= $24,248
- Mod P000022024-06-07-$16,193= $8,055
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2023-10-01 | +$12,124 | $12,124 | EO14042 - THERAPEUTIC APHERESIS SERVICES |
| Mod P00001· EXERCISE AN OPTION | 2023-12-12 | +$12,124 | $24,248 | EO14042 - THERAPEUTIC APHERESIS SERVICES |
| Mod P00002· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2024-06-07 | −$16,193 | $8,055 | THERAPEUTIC APHERESIS SERVICES |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI G69LHXJ3ABL5)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C25226N0550 | 252-NETWORK CONTRACT OFFICE 12 (36C252) · 6505 · DRUGS AND BIOLOGICALS | $2,500 | FY2026 |
| 36C25226N0551 | 252-NETWORK CONTRACT OFFICE 12 (36C252) · 6505 · DRUGS AND BIOLOGICALS | $2,100 | FY2026 |
| 36C25226N0549 | 252-NETWORK CONTRACT OFFICE 12 (36C252) · 6505 · DRUGS AND BIOLOGICALS | $170 | FY2026 |
| 36C25226N0548 | 252-NETWORK CONTRACT OFFICE 12 (36C252) · 6505 · DRUGS AND BIOLOGICALS | $10,000 | FY2026 |
| 36C25026P0816 | 250-NETWORK CONTRACT OFFICE 10 (36C250) · 6640 · LABORATORY EQUIPMENT AND SUPPLIES | $19,329 | FY2026 |
| 36C24126N0603 | 241-NETWORK CONTRACT OFFICE 01 (36C241) · 6505 · DRUGS AND BIOLOGICALS | $1,998,719 | FY2026 |
Other recipients under Q508 from 260-NETWORK CONTRACT OFFICE 20 (36C260) (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| 36C26023N0376 | UNIVERSITY OF WASHINGTON | 260-NETWORK CONTRACT OFFICE 20 (36C260) | $319,752 | FY2023 |
| 36C26020N0506 | UNIVERSITY OF WASHINGTON | 260-NETWORK CONTRACT OFFICE 20 (36C260) | $41,752 | FY2020 |
| 36C26020N0334 | SYSMEX AMERICA, INC | 260-NETWORK CONTRACT OFFICE 20 (36C260) | $44,155 | FY2020 |
| 36C26019N0529 | UNIVERSITY OF WASHINGTON | 260-NETWORK CONTRACT OFFICE 20 (36C260) | $238,357 | FY2019 |
| 36C26019D0009 | UNIVERSITY OF WASHINGTON | 260-NETWORK CONTRACT OFFICE 20 (36C260) | $0 | FY2019 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C26024N0043_3600_36C26018D0078_3600 · retrieved 2026-09-26.